Vident Investment Advisory, LLC Cardiol Therapeutics Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.48 - $1.0 $660 - $1,375
1,375 Added 0.95%
146,807 $74,000
Q3 2022

Nov 14, 2022
BUY
$1.02 - $1.41 $9,770 - $13,506
9,579 Added 7.05%
145,432 $149,000
Q2 2022

Aug 15, 2022
BUY
$1.03 - $2.05 $9,986 - $19,876
9,696 Added 7.69%
135,853 $178,000
Q1 2022

May 16, 2022
BUY
$1.25 - $2.31 $91,890 - $169,812
73,512 Added 139.64%
126,157 $195,000
Q4 2021

Feb 14, 2022
BUY
$1.83 - $4.86 $3,804 - $10,103
2,079 Added 4.11%
52,645 $97,000
Q3 2021

Nov 12, 2021
BUY
$2.03 - $4.8 $102,648 - $242,716
50,566 New
50,566 $208,000

Others Institutions Holding CRDL

# of Institutions
45
Shares Held
5.07M
Call Options Held
5.2K
Put Options Held
9.5K
View Full List

About Cardiol Therapeutics Inc.

CRDL Quotes by TradingView
  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $94.8M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email